Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about INEBILIZUMAB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| B cell subset counts | downregulates | phenotype | 0.95 |
| CD20 | targets | protein | 0.90 |
| NEUROMYELITIS OPTICA SPECTRUM DISORDER | treats | entity | 0.90 |
| Neuromyelitis Optica Spectrum Disorder | treats | disease | 0.90 |
| CD19+ B Cells | targets | cell_type | 0.90 |
| Cd19 | targets | biomarker | 0.90 |
| CD20 | inhibits | entity | 0.90 |
| B Cell | downregulates | cell_type | 0.90 |
| Neuromyelitis Optica | treats | disease | 0.80 |
| AQP4-IgG+ NMOSD attacks | prevents | phenotype | 0.70 |
| NMOSD attacks | prevents | phenotype | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CD20+ B Cells | targets | cell_type | 0.90 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.690
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning INEBILIZUMAB in their description or question text
No additional research found